The underlying mechanism of pruritus in LP remains unknown; however, similar responses were seen with topical JAK1/2 inhibition with topical ruxolitinib, implying that JAK1 and/or JAK2 play a central role in LP pruritus (16). The gene discussed is JAK1; the disease is Pruritus.